seroconvert

v.

血清転換する、抗体陽転する

関: seroconversion

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/03/09 06:50:59」(JST)

wiki en

In immunology, seroconversion is the time period during which a specific antibody develops and becomes detectable in the blood. After seroconversion has occurred, the disease can be detected in blood tests for the antibody. During an infection or immunization, antigens enter the blood, and the immune system begins to produce antibodies in response. Before seroconversion, the antigen itself may or may not be detectable, but the antibody is, by definition, absent. During seroconversion, the antibody is present but not yet detectable. Any time after seroconversion, the antibodies can be detected in the blood, indicating a prior or current infection.

Mechanism

The physical structure of an antibody allows it to bind to a specific antigen to form a complex. Because of this binding, if the amounts of antigen and antibody in the blood are equal, each molecule will be in a complex and be undetectable. The antibody or antigen is only detectable in the blood when there is more of one than the other.

Early in an infection, the antigen molecules outnumber the antibody molecules, and there will be unbound antigen that may be detectable, while all the antibody molecules are bound. After seroconversion, there is more antibody than antigen, so there is a detectable amount of free antibody, while all the antigen is bound and undetectable.

Terminology

During seroconversion, when the amounts of antibody and antigen are very similar, it may not be possible to detect free antigen or free antibody. This may give a false negative result when testing for the infection. This time is referred to as the window period.

Serology (testing for antibodies) is used to determine if specific antibodies are in an organism's blood. Serostatus is a term denoting the presence or absence of particular antibodies in an individual's blood. Before seroconversion, the blood test is seronegative for the antibody; after seroconversion, the blood test is seropositive for the antibody.

The word seroconversion is often used in reference to blood testing for anti-HIV antibodies. In particular, "seroconverted" has been used to refer to the process of having "become HIV positive".

Seroreversion is the opposite of seroconversion. This is when the tests can no longer detect antibodies in a patient’s serum.^[1]

Background

The immune system maintains an "immunological memory" of infectious pathogens to facilitate early detection and to confer protective immunity against a rechallenge. This explains why many childhood diseases never recur in adulthood (and when they do, it generally indicates immunosuppression or failure of a vaccine).

In the initial (primary infection) phase of the infection, immunoglobulin M (IgM) antibodies are produced and as these levels drop (and become undetectable) immunoglobulin G (IgG) levels rise and remain detectable. Upon reinfection, IgM antibodies usually do not rise again but IgG levels will increase. Thus an elevated IgM titre indicates recent primary infection, while the presence of IgG suggests past infection or immunization.

References

^ Tantalo et al., JID 2005:191; "Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model"

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 妊娠中の水痘帯状疱疹ウイルス感染 varicella zoster virus infection in pregnancy
2. 麻疹の予防および治療 prevention and treatment of measles
3. 成人における再発寛解型多発性硬化症に対するナタリズマブ natalizumab for relapsing remitting multiple sclerosis in adults
4. 成人におけるHIVへの非職業的曝露 nonoccupational exposure to hiv in adults
5. 小児および思春期におけるB型肝炎ウイルス感染の概要 overview of hepatitis b virus infection in children and adolescents

English Journal

Risk Factors for Early Mortality on Antiretroviral Treatment of Elderly People Infected with HIV in Burkina Faso.

Ouédraogo DD1, Sawadogo LM2, Sagna Y2, Sawadogo AB3, Diallo I2, Hema A3, Poda A3, Drabo YJ2.
Journal of the International Association of Providers of AIDS Care.J Int Assoc Provid AIDS Care.2014 Oct 7. pii: 2325957414553841. [Epub ahead of print]
BACKGROUND: Age is a key determinant of mortality due to diseases including HIV infection.METHODS: A retrospective and descriptive cohort study used a computerized database to compare HIV-infected patients diagnosed in late adulthood to a group of patients diagnosed before their 49 years of age, wit
PMID 25294855

First Case of Zika Virus Infection in a Returning Canadian Traveler.

Fonseca K1, Meatherall B2, Zarra D2, Drebot M2, MacDonald J2, Pabbaraju K2, Wong S2, Webster P2, Lindsay R2, Tellier R2.
The American journal of tropical medicine and hygiene.Am J Trop Med Hyg.2014 Oct 6. pii: 14-0151. [Epub ahead of print]
A woman who recently traveled to Thailand came to a local emergency department with a fever and papular rash. She was tested for measles, malaria, and dengue. Positive finding for IgM against dengue and a failure to seroconvert for IgG against dengue for multiple blood samples suggested an alternate
PMID 25294619

Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.

Hsu JP, Zhao X, Chen MI1, Cook AR, Lee V, Lim WY, Tan L, Barr IG, Jiang L, Tan CL, Phoon MC, Cui L, Lin R, Leo YS, Chow VT.
BMC infectious diseases.BMC Infect Dis.2014 Jul 28;14:414. doi: 10.1186/1471-2334-14-414.
BACKGROUND: The rate of decline of antibody titers to influenza following infection can affect results of serological surveys, and may explain re-infection and recurrent epidemics by the same strain.METHODS: We followed up a cohort who seroconverted on hemagglutination inhibition (HI) antibody titer
PMID 25066592

Japanese Journal

現在使用されている水痘ワクチンの力価の必要性

感染症学雑誌 : 日本伝染病学会機関誌 : the journal of the Japanese Association for Infectious Diseases 86(6), 749-754, 2012-11-20
NAID 10031176205

豚コレラウイルスの空気伝播におけるワクチン効果(ウィルス学)

The journal of veterinary medical science 63(9), 991-996, 2001-08-25
NAID 110003920733

Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment